OGT Signs Licensing Deal for Colorectal Cancer Biomarkers
Thursday, February 23, 2012
OGT has entered into an exclusive licensing agreement with Inven2.
NIH Common Fund Researchers Uncover Structure of Important Target for Drug Design
Tuesday, February 21, 2012
Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor.
"Popeye" Proteins Help the Heart Adapt to Stress
Tuesday, February 21, 2012
Study help scientists to develop new treatments for abnormal heart rhythms.
EPI Collaborates with the University of Texas MD Anderson Cancer Center
Tuesday, February 14, 2012
EPI collaborates on Liquid Tissue® personalized medicine assays in lung cancer treatment.
Quincy Bioscience Begins Recruitment for Migraine Study
Monday, February 13, 2012
Study will evaluate the effectiveness of the jellyfish calcium-binding protein apoaequorin on quality of life for migraine sufferers.
Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer
Friday, February 10, 2012
Mr. Zaniboni's experience includes raising more than $500 million through venture financing and IPO proceeds.
SemBioSys and Tasly Pharmaceutical to Participate in the 5th CCBF and Signing Ceremony
Thursday, February 09, 2012
New joint venture focused on multi-million dollar short-term revenue opportunities.
Applied Proteomics Appoints CEO Following Series B Financing
Wednesday, February 08, 2012
Applied Proteomics Inc. announce the appointment of Peter Klemm, Ph.D., as chief executive officer after securing $22.5 million Series B financing.
Rapid Bone Loss Possible Side Effect of Anti-Obesity Drug
Tuesday, February 07, 2012
Research from UT Southwestern Medical Center has raised concern about the safe use of fibroblast growth factor 21.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 1737 |
|
|
